Top Markets
Coin of the day
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

SPPI
Rank in Stocks #21095
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily... Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induced neutropenia. Also under development is Poziotinib, a distinct irreversible tyrosine kinase inhibitor intended for non-small cell lung cancer tumors exhibiting various mutations. Furthermore, Anti-CD20-IFNa, an antibody-interferon fusion molecule targeting CD20, is progressing through Phase I development for patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. The company maintains key collaborative agreements, such as co-development, commercialization, and in-licensing arrangements with Hanmi Pharmaceutical Co. Ltd., a patent and technology license with The University of Texas M.D. Anderson Cancer Center, and an in-license pact with ImmunGene, Inc. Founded in 1987, and initially known as NeoTherapeutics, Inc. before its name change in December 2002, Spectrum Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Share Price
$1.03
Last synced: 2023-07-31
Market Cap
$115.13M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Spectrum Pharmaceuticals, Inc. (SPPI)

Category

Stock price history for Spectrum Pharmaceuticals, Inc. (SPPI)
Highest end of day price: $0.98 on 2023-07-01

Lowest end of day price: $146.88 on 1996-09-01
Stock price history of Spectrum Pharmaceuticals, Inc. from 1996 to 2026
Annual Stock Price Performance
Year Performance
2023 142.39%
2022 -72.40%
2021 -66.76%
2020 -45.64%
2019 -24.79%
2018 -42.30%
2017 324.76%
2016 -24.40%
2015 -18.21%
2014 -20.89%
2013 -20.68%
2012 -21.84%
2011 142.92%
2010 27.82%
2009 208.32%
2008 -48.89%
2007 -47.10%
2006 36.47%
2005 -30.49%
2004 -16.52%
2003 256.95%
2002 -97.89%
2001 -26.14%
2000 -57.96%
1999 39.74%
1998 -8.28%
1997 119.65%
1996 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH